Score Breakdown
Trash.
Amprius has genuinely differentiated silicon anode technology with strong energy density advantages in defense/drone applications, but the stock is egregiously overvalued at ~$2.2B market cap for a company generating $90M TTM revenue with deeply negative margins, ~13 months of cash runway, 16% annual dilution, and 45% revenue exposure to a war zone. The bill-and-hold revenue recognition (21% of 2025 revenue), massive insider selling ($40M+ in 6 months), customer concentration, and inevitable need for additional capital raises make this a poor risk/reward at current levels. Even assuming aggressive growth to $200M+ revenue by 2027, the path to sustainable positive FCF is years away, and the current P/S of ~25x implies near-flawless execution that the company has not demonstrated. The 30% post-earnings decline signals the market is beginning to price in these risks, but valuation remains extreme.
Negative cash flow. Can't value it.
Some yellow flags.
Slow bleed.
Neutral.
Tight but ok.
Significant shorts.
Below average.
🐻 Why Bears Hate It
The bear case centers on the company's inability to translate massive revenue growth into profitability. Despite a 153% YoY revenue increase, AMPX continues to suffer from steep negative operating margins (roughly -60%) and even worse pretax margins (-123%). With a price-to-sales ratio hovering around 41 and a price-to-book near 29, the stock is priced for perfection, leaving it highly vulnerable to guidance misses and 'sell the news' events (StocksToTrade, May 2026).
🔍 What's In The SEC Filings
The risk profile is dominated by the typical structural dilution of a de-SPAC and the opacity permitted by its Emerging Growth Company status.
Substantial warrant overhang poses a threat to common shareholder equity.
“Redeemable warrants, each exercisable for one share of common stock at an exercise price of $11.50”
The presence of redeemable warrants creates a ceiling on stock price appreciation and suggests future dilutive events if the share price exceeds the $11.50 threshold.
Reliance on Emerging Growth Company status reduces reporting transparency.
“Entity Emerging Growth Company: ['true']”
This status allows the company to provide reduced disclosures regarding executive compensation and, more critically, grants an exemption from the auditor attestation requirements of Section 404(b) of the Sarbanes-Oxley Act.
Valuation should include a discount for the warrant exercise potential and the lack of internal control transparency inherent in the 'Emerging Growth' designation.
The lack of actual financial data (income statement or balance sheet) in this specific 8-K transmission makes it impossible to assess the current cash burn or operational runway.